UK 3d Bioprinting Market Size & Outlook, 2023-2030
UK 3d bioprinting market, 2018-2030 (US$M)
Related Markets
UK 3d bioprinting market highlights
- The UK 3d bioprinting market generated a revenue of USD 79.8 million in 2023 and is expected to reach USD 158.5 million by 2030.
- The UK market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating application in 2023.
- Dental is the most lucrative application segment registering the fastest growth during the forecast period.
3d bioprinting market data book summary
| Market revenue in 2023 | USD 79.8 million |
| Market revenue in 2030 | USD 158.5 million |
| Growth rate | 10.3% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Dental |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dental, Medical, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product |
| Key market players worldwide | EnvisionTEC, Organovo Holdings Inc, 3D Systems Corp, Inventia Life, Poietis, Vivax Bio, Cyfuse Biomedical, Cellink, Regemat 3D |
Other key industry trends
- In terms of revenue, UK accounted for 3.4% of the global 3d bioprinting market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany 3d bioprinting market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 143.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
3D Bioprinting Market Scope
3D Bioprinting Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK 3d bioprinting market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d bioprinting market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 38.47% in 2023. Horizon Databook has segmented the UK 3d bioprinting market based on dental, medical, biosensors, consumer/personal product testing, bioinks, food and animal product covering the revenue growth of each sub-segment from 2018 to 2030.
The rising funding for research and the ongoing advancements in material composition, such as the increasing use of advanced metals & polymers, is a major factor boosting market growth in the UK. Furthermore, the presence of major research organizations is driving the healthcare AM market growth in the UK.
The clinical need for organ and tissue replacement therapy is growing, and patients in the UK are required to wait for organ transplants. This rising need is expected to create a demand for 3D printing technology.
This system’s goal is to advance the Royce vision and commercialize bioprinting discoveries (such as tissue/organ analogues) that could have positive socioeconomic effects on human biology, medicine, and drug development in the UK.
Reasons to subscribe to UK 3d bioprinting market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK 3d bioprinting market databook
-
Our clientele includes a mix of 3d bioprinting market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK 3d bioprinting market , including forecasts for subscribers. This country databook contains high-level insights into UK 3d bioprinting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK 3d bioprinting market size, by application, 2018-2030 (US$M)
UK 3D Bioprinting Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
